These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38161348)

  • 21. Amphotericin B: time for a new "gold standard".
    Ostrosky-Zeichner L; Marr KA; Rex JH; Cohen SH
    Clin Infect Dis; 2003 Aug; 37(3):415-25. PubMed ID: 12884167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis.
    Sun HY; Alexander BD; Lortholary O; Dromer F; Forrest GN; Lyon GM; Somani J; Gupta KL; del Busto R; Pruett TL; Sifri CD; Limaye AP; John GT; Klintmalm GB; Pursell K; Stosor V; Morris MI; Dowdy LA; Munoz P; Kalil AC; Garcia-Diaz J; Orloff S; House AA; Houston S; Wray D; Huprikar S; Johnson LB; Humar A; Razonable RR; Husain S; Singh N
    Clin Infect Dis; 2009 Dec; 49(11):1721-8. PubMed ID: 19886800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review.
    Flamm SL; Wong F; Ahn J; Kamath PS
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2707-2716. PubMed ID: 36075500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicity and efficacy of conventional amphotericin B deoxycholate versus escalating doses of amphotericin B deoxycholate---fat emulsion in HIV-infected patients with oral candidosis.
    Chavanet P; Clement C; Duong M; Buisson M; D'Athis P; Dumas M; Bonnin A; Portier H
    Clin Microbiol Infect; 1997 Aug; 3(4):455-461. PubMed ID: 11864156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Respiratory distress secondary to both amphotericin B deoxycholate and lipid complex formulation.
    Rolland WA; Guharoy R; Ramirez L; Blair D; Medicis J; Khan U
    Vet Hum Toxicol; 2000 Aug; 42(4):222-3. PubMed ID: 10928687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation of clinical practice policy on the continuous intravenous administration of amphotericin B deoxycholate.
    Maharom P; Thamlikitkul V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S118-24. PubMed ID: 17718252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis.
    Clemons KV; Schwartz JA; Stevens DA
    Med Mycol; 2011 Nov; 49(8):834-47. PubMed ID: 21539507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous itraconazole vs. amphotericin B deoxycholate for empirical antifungal therapy in patients with persistent neutropenic fever.
    Park SH; Choi SM; Lee DG; Choi JH; Yoo JH; Min WS; Shin WS
    Korean J Intern Med; 2006 Sep; 21(3):165-72. PubMed ID: 17017665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. continuous versus conventional infusion of amphotericin B deoxycholate: a meta-analysis.
    Falagas ME; Karageorgopoulos DE; Tansarli GS
    PLoS One; 2013; 8(10):e77075. PubMed ID: 24204739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrathecal Amphotericin B: A 60-Year Experience in Treating Coccidioidal Meningitis.
    Ho J; Fowler P; Heidari A; Johnson RH
    Clin Infect Dis; 2017 Feb; 64(4):519-524. PubMed ID: 27927853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complexing amphotericin B with gold nanoparticles improves fungal clearance from the brains of mice infected with Cryptococcal neoformans.
    Chintalacharuvu KR; Matolek ZA; Pacheco B; Carriera EM; Beenhouwer DO
    Med Mycol; 2021 Nov; 59(11):1085-1091. PubMed ID: 34332505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of cryptococcosis in renal transplant recipients in a less-resourced health care system.
    Ponzio V; Camargo LF; Medina-Pestana J; Perfect JR; Colombo AL
    Transpl Infect Dis; 2018 Aug; 20(4):e12910. PubMed ID: 29677399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Amphotericin B deoxycholate prescription and adverse events in a Chilean university hospital].
    Quinteros A R; Fica C A; Abusada A N; Muñoz C L; Novoa M C; Gallardo A C
    Rev Chilena Infectol; 2010 Feb; 27(1):25-33. PubMed ID: 20140311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of murine cryptococcosis with liposome-associated amphotericin B.
    Graybill JR; Craven PC; Taylor RL; Williams DM; Magee WE
    J Infect Dis; 1982 May; 145(5):748-52. PubMed ID: 7077097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nephrotoxins and acute kidney injury - The consensus of the Taiwan acute kidney injury Task Force.
    Huang WC; Wang MT; Lai TS; Lee KH; Shao SC; Chen CH; Su CH; Chen YT; Sung JM; Chen YC
    J Formos Med Assoc; 2022 May; 121(5):886-895. PubMed ID: 34998658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expert consensus on rational clinical application of amphotericin B deoxycholate (2022)].
    ; ;
    Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(16):1173-1183. PubMed ID: 37087401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should we continue using amphotericin B deoxycholate for the treatment of fungal infections? Adverse events and clinical outcomes.
    Garbino J; Markham L; Matulionyte R; Rives V; Lew D
    Scand J Infect Dis; 2006; 38(2):110-3. PubMed ID: 16449001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence, Predictors, and Impact on Hospital Mortality of Amphotericin B Nephrotoxicity Defined Using Newer Acute Kidney Injury Diagnostic Criteria.
    Rocha PN; Kobayashi CD; de Carvalho Almeida L; de Oliveira Dos Reis C; Santos BM; Glesby MJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4759-69. PubMed ID: 26014956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin D and experimental invasive aspergillosis.
    Sirivoranankul C; Martinez M; Chen V; Clemons KV; Stevens DA
    Med Mycol; 2014 Nov; 52(8):847-52. PubMed ID: 25231772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk Stratification of Acute Kidney Injury Using the Blood Urea Nitrogen/Creatinine Ratio in Patients With Acute Decompensated Heart Failure.
    Takaya Y; Yoshihara F; Yokoyama H; Kanzaki H; Kitakaze M; Goto Y; Anzai T; Yasuda S; Ogawa H; Kawano Y
    Circ J; 2015; 79(7):1520-5. PubMed ID: 25854814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.